Advertisement
Loading...

Sol-Gel Technologies Ltd.

SLGL•NASDAQ
Healthcare
Biotechnology
$68.68
$-4.37(-5.98%)
U.S. Market opens in 2h 17m

Sol-Gel Technologies Ltd. (SLGL) Stock Overview

Explore Sol-Gel Technologies Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap189.1M
P/E Ratio-31.24
EPS (TTM)$-2.19
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$79.20
3 Months$102.56
1 Year Target$92.08

SLGL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sol-Gel Technologies Ltd. (SLGL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.24 and a market capitalization of 189.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.87%
5-Day Change
-1.03%
1-Month Change
-12.03%
3-Month Change
0.15%
6-Month Change
97.94%
Year-to-Date (YTD) Change
59.71%
1-Year Change
761.72%
3-Year Change
97.94%
5-Year Change
-31.33%
All-Time (Max) Change
-50.66%

Contact Information

https://www.sol-gel.com
972 8 931 3433
7 Golda Meir Street, Ness Ziona, NaN, 7403650

Company Facts

34 Employees
IPO DateFeb 1, 2018
CountryIL
Actively Trading

Frequently Asked Questions